iData Research Logo

A Trusted Source of Intelligent Data

  • Solutions
    • Subscription Model *NEW*
    • Healthcare Market Reports
    • MedSKU Brand Analysis
    • Procedure Tracker
    • Medical Market Surveys
    • Total Sales Solution
    • Custom Consulting
    • iData Pharma
    • iData Online
  • Reports
  • Platforms
  • News
    • MedTech Future
    • CardioFuture
    • DentalFuture
    • OrthoFuture
    • COVID-19
    • Press Releases
  • About Us
    • About Us
    • Do it Right
    • Research Methodology
    • Careers
    • Testimonials
    • FAQs
  • Contact Us
  • Serach
  • Login
Sign In
  • Home
  • Market Potential of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate
Search for:

Category: Orthopedic Biomaterials

Market Potential of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate

Market Potential of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate

Andrew Sung 11/02/2025
The prevalence of bone diseases is rising worldwide as the aging population of individuals who are 55+ continues to grow. This has led to an increasing demand for Bone Graft Substitutes (BGS) to suppo... Read More
European Orthopedic Biomaterials Market: Key Competitors and Trends

European Orthopedic Biomaterials Market: Key Competitors and Trends

Sabina Y 12/11/2024
As highlighted in our recent report, European Orthopedic Biomaterials, the market is projected to reach €643 million by 2028, reflecting a compound annual growth rate (CAGR) of 7.6%. Driven by innov... Read More
Renovos Attains FDA Breakthrough Device Designation for RENOVITE® BMP-2

Renovos Attains FDA Breakthrough Device Designation for RENOVITE® BMP-2

Emma Matrick 16/01/2024
Renovos, a pioneering biotechnology company, proudly announces its recent achievement of Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its groundbreaking product, ... Read More
Orthopedic Bone Graft Substitutes: The Global Market Over the Next 7 Years

Orthopedic Bone Graft Substitutes: The Global Market Over the Next 7 Years

Emma Matrick 09/01/2023
In 2022, the global orthopedic bone graft substitutes (BGS) market was valued at approximately $2 billion. Compared to 2022, the market was valued at slightly under $2 billion in 2021 because of COVID... Read More
What are the Most Popular Demineralized Bone Matrices by Brand in the U.S.?

What are the Most Popular Demineralized Bone Matrices by Brand in the U.S.?

Emma Matrick 14/12/2022
iData Research recently completed a detailed SKU-level analysis on the U.S. market for orthobiologics. The analysis includes an overview of the companies and products for the following segments: bone ... Read More
Analyst Q&A: Orthopedic Biomaterials and the European Market

Analyst Q&A: Orthopedic Biomaterials and the European Market

Emma Matrick 24/05/2022
Retrieved from: Fidia Pharma iData’s analysts work extensively to retrieve data and source both syndicated and custom market research reports. Due to their in-depth understanding of the markets and ... Read More
Orthopedic Biomaterial Devices: Top Brands per Segment in the U.S.

Orthopedic Biomaterial Devices: Top Brands per Segment in the U.S.

Emma Matrick 07/02/2022
Infuse bone graft (Medtronic) Within the U.S. Orthopedic Biomaterials market, multiple segments are discussed including bone graft substitutes, cellular allografts, and growth factors. Bone graft subs... Read More
$4.7 Billion Dollars: How the U.S. Orthopedic Biomaterials Market is Growing

$4.7 Billion Dollars: How the U.S. Orthopedic Biomaterials Market is Growing

Emma Matrick 08/12/2021
Medtronic’s INFUSE™ Bone Graft Substitute. Retrieved from drugwatch.com. iData is excited to announce one of our brand-new 2022 market reports on the U.S. orthopedic biomaterials market. As ex... Read More
Top Orthopedic Companies in the United States

Top Orthopedic Companies in the United States

iData Research 19/03/2021
Did you know there are over 8.9 million orthopedic procedures performed in the United States each year, with the orthopedic biomaterials market showing the greatest forecast growth? As this market c... Read More
Are Genetically Engineered Cells the Future of Osteoarthritis Treatment?

Are Genetically Engineered Cells the Future of Osteoarthritis Treatment?

iData Research 12/02/2021
The growing elderly demographic has been a considerable market driver within the orthopedic biomaterials market, the incidence of osteoarthritis and other forms of degenerative diseases have also been... Read More
  • 1 of 4
  • 1
  • 2
  • 3
  • 4
  • Next »

    Want more information about the market report mentioned in this article?

    Free Sample Report
    Subscribe to iData News

    We publish medical, dental, and pharmaceutical news and market insights from our analysts every day. Sign up for your free subscription here:

    Subscribe
  • [save_as_pdf_pdfcrowd]
+

Free Sample Report

    [create_popup_free_sample_report_rorm_v6]

    Subscribe to our Newsletter
    Subscribe

    OUR ADDRESS

    • 602-7300 Edmonds St, Kings Crossing, Burnaby, BC V3N 0G8, Canada
    • 8 The Green #21910, Dover, DE, 19901, United States
    • +1 (604) 266-6933
    • info@idataresearch.net

    SOLUTIONS

    • Report
    • Custom Consulting
    • MedSKU Brand Analysis
    • Procedure Tracker
    • Surveys
    • Total Sales Solution
    • Pharmaceuticals
    • iDataOnline

    NEWS

    • Blog
    • MedTech Future
    • Cardio Future
    • Dental Future
    • Ortho Future
    • Subscribe

    ABOUT US

    • About iData
    • Our Methodology
    • Testimonials
    • FAQ
    • Careers

    OTHER

    • Terms of Use
    • Privacy Policy
    • Sitemap

    Copyright © 2005 - 2026 iData Research. All Rights Reserved